Global drug giant Pfizer is warning physicians and clinicians in India to immediately stop using four of its antibiotics due to manufacturing issues at a contract producer.
German drugmaker Fresenius warned that stricter production norms being considered by Europe’s drug regulator could compound shortages of a life-saving antibiotic that is used by about 25 million patients globally each year.
Access to Medicine Foundation warns that urgent action is needed to rebuild the antibiotics market